Medication Nonadherence: The Role of Cost, Community, and Individual Factors

Health Services Research

Volumn 52, Issue 4, 2017, Pages 1511-1533

  Abbass, Ibrahim ^a   Revere, Lee ^a   Mitchell, Jordan ^b   Appari, Ajit ^a  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF HOUSTON CLEAR LAKE   (United States)

Author keywords

cost sharing; health care utilization; Medication adherence; out of pocket expense

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGE; ARTICLE; COHORT ANALYSIS; COMMUNITY; COMMUNITY LEVEL FACTOR; COMORBIDITY; CONCEPTUAL FRAMEWORK; CONTROLLED STUDY; EDUCATIONAL STATUS; ETHNICITY; FEMALE; HEALTH BELIEF; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HEALTH SERVICE; HUMAN; INSURANCE; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; OUT OF POCKET COST; PATIENT ATTITUDE; POVERTY; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SOCIAL COGNITIVE THEORY; SOCIOECONOMICS; TREATMENT REFUSAL; ADOLESCENT; BLUE CROSS BLUE SHIELD; DRUG COST; ECONOMICS; FINANCIAL MANAGEMENT; MIDDLE AGED; STATISTICAL MODEL; TEXAS; UTILIZATION; YOUNG ADULT;

ADOLESCENT; ADULT; BLUE CROSS BLUE SHIELD INSURANCE PLANS; DRUG COSTS; FEMALE; FINANCING, PERSONAL; HEALTH SERVICES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INSURANCE CLAIM REVIEW; LINEAR MODELS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; RETROSPECTIVE STUDIES; TEXAS; YOUNG ADULT;

EID: 84992153299     PISSN: 00179124     EISSN: 14756773     Source Type: Journal    
DOI: 10.1111/1475-6773.12547     Document Type: Article

References (83)

1. Aday, L. A., and R. M. Andersen. 1974. “A Framework for the Study of Access to Medical Care.” Health Services Research 9: 208–20.
2. Andersen, R. M. 1995. “Revisiting the Health Behavioral Model and Access to Medical Care: Does it Matter?” Journal of Health and Social Behavior 36 (1): 1–10.
3. Andersen, R. M., and J. F. Newman. 1973. “Societal and Individual Determinants of Medical Care Utilization in the United States.” Milbank Quarterly 51 (1): 95–124.
4. Bandura, A. 2004. “Health Promotion by Social Cognitive Means.” Health Education and Behavior 31: 143–64.
5. Benner, J. S., R. J. Glynn, H. Mogun, P. J. Neumann, M. C. Weinstein, and J. Avorn. 2002. “Long-Term Persistence in Use of Statin Therapy in Elderly Patients.” Journal of the American Medical Association 288: 455–61.
6. Benner, J. S., J. C. Tierce, C. M. Ballantyne, C. Prasad, M. F. Bullano, V. J. Willey, J. Erbey, and D. S. Sugano. 2004. “Follow-up Lipid Tests and Physician Visits Are Associated with Improved Adherence to Statin Therapy.” Pharmacoeconomics 22 (suppl 3): 13–23.
7. Blanchard, J., J. M. Madden, D. Ross-Degnan, C. R. Gresenz, and S. B. Soumerai. 2013. “The Relationship between Emergency Department Use and Cost-Related Medication Nonadherence among Medicare Beneficiaries.” Annals of Emergency Medicine 62 (5): 475–85.
8. Briesacher, B. A., J. H. Gurwitz, and S. B. Soumerai. 2007. “Patients At-Risk for Cost Related Medication Nonadherence: A Review of the Literature.” Journal of General Internal Medicine 22: 864–71.
9. Chan, D. C., W. H. Shrank, and D. Cutler. 2010. “Patient, Physician, and Payment Predictors of Statin Adherence.” Medical Care 48 (3): 196–202.
10. Chodick, G., V. Shalev, Y. Gerber, A. D. Heymann, H. Silber, V. Simah, and E. Kokia. 2008. “Long-Term Persistence with Statin Treatment in a Not-For-Profit Health Maintenance Organization: A Population-based Retrospective Cohort Study in Israel.” Clinical Therapeutics 30 (11): 2167–79.
11. Choudhry, N. K., M. A. Fischer, J. Avorn, S. Schneeweiss, D. H. Solomon, C. Berman, S. Jan, J. Liu, J. Lii, M. A. Brookhart, and J. J. Mahoney. 2010. “At Pitney Bowes, Value-Based Insurance Design Cut Copayments and Increased Drug Adherence.” Health Affairs 29 (11): 1995–2001.
12. Chu, L. H., A. Kawatkar, and A. Gu. 2011. “SAS Macro Program to Calculate Medication Adherence Rate for Single and Multiple Medication Use.” In Western Users of SAS Software Conference, pp. 12–14. San Francisco, CA.
13. Claxton, A. J., J. Cramer, and C. Pierce. 2001. “A Systematic Review of the Associations between Dose Regimens and Medication Compliance.” Clinical Therapeutics 23 (8): 1296–310.
14. CMS (Centers for Medicare and Medicaid Services). 2010. “Enhancements to Medicare Part D Patient Safety Reports” [accessed on April 16, 2014]. Available at http://www.cms.gov/Medicare/Pre-script-ion-DrugCoverage/PrescriptionDrugCovContra/index.html
15. CMS (Centers for Medicare and Medicaid Services). 2014. “Quality Measures” accessed on August 1, 2016. Available at https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/QualityMeasures/index.html?redirect=/QUALITYMEASURES/
16. Conn, V. S., M. Enriquez, T. M. Ruppar, and K. C. Chan. 2014. “Cultural Relevance in Medication Adherence Interventions with Underrepresented Adults: Systematic Review and Meta-Analysis of Outcomes.” Preventive Medicine 69: 239–47.
17. Craig, B. M., B. B. Reeve, D. Cella, R. D. Hays, A. S. Pickard, and D. A. Revicki. 2014. “Demographic Differences in Health Preferences in the United States.” Medical Care 52: 307–13.
18. Cramer, J. A. 2004. “A Systematic Review of Adherence with Medications for Diabetes.” Diabetes Care 27 (5): 1218-24.
19. Cummings, M. K., M. H. Becker, J. P. Kirscht, and N. W. Levin. 1982. “Psychosocial Factors Affecting Adherence to Medical Regimens in a Group of Hemodialysis Patients.” Medical Care 20 (6): 567–80.
20. Cummins, S., S. Curtis, A. V. Diez-Roux, and S. Macintyre. 2007. “Understanding and Representing ‘Place’ in Health Research: A Relational Approach.” Social Science & Medicine 65 (9): 1825–38.
21. Daviglus, M. L., A. Pirzada, and G. A. Talavera. 2014. “Cardiovascular Disease Risk Factors in the Hispanic/Latino Population: Lessons from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).” Progress in Cardiovascular Diseases 57 (3): 230–6.
22. Desai, P. R., A. O. Adeyemi, K. M. Richards, and K. A. Lawson. 2014. “Adherence to Oral Diabetes Medications among Users and Nonusers of Antipsychotic Medication.” Psychiatric Services 65 (2): 215–20.
23. DeVol, R., A. Bedroussian, A. Charuworn, A. Chatterjee, I. K. Kim, S. Kim, and K. Klowden. 2007. “An Unhealthy America: The Economic Burden of Chronic Disease – Charting a New Course to Save Lives and Increase Productivity and Economic Growth” [accessed on April 16, 2014]. Available at http://www.chronicdiseaseimpact.com/
24. Donnelly, L. A., A. S. Doney, A. D. Morris, C. N. Palmer, and P. T. Donnan. 2008. “Long–term Adherence to Statin Treatment in Diabetes.” Diabetic Medicine 25: 850–5.
25. Eaddy, M. T., C. L. Cook, K. O'Day, S. P. Burch, and R. Cantrell. 2012. “How Patient Cost–sharing Trends Affect Medication Adherence and Outcomes.” Pharmacy & Therapeutics 37 (1): 45–55.
26. Ellis, J. J., S. R. Erickson, J. G. Stevenson, S. J. Bernstein, R. A. Stiles, and A. M. Fendrick. 2004. “Suboptimal Statin Adherence and Discontinuation in Primary and Secondary Prevention Populations: Should We Target Patients with the Most to Gain?” Journal of General Internal Medicine 19: 638–45.
27. Franzini, L., J. C. Ribble, and A. M. Keddie. 2001. “Understanding the Hispanic Paradox.” Ethnicity and Disease 11 (3): 496-518.
28. Gellad, W. F., J. L. Grenard, and Z. A. Marcum. 2011. “A Systematic Review of Barriers to Medication Adherence in the Elderly: Looking Beyond Cost and Regimen Complexity.” The American Journal of Geriatric Pharmacotherapy 9 (1): 11–23.
29. Gibson, T. B., T. L. Mark, K. Azelsen, O. Baser, D. A. Rublee, and K. A. McGuigan. 2006. “Impact of Statin Copayments on Adherence and Medical Care Utilization and Expenditures.” The American Journal of Managed Care 12 (12): SP11–9.
30. Gibson, T. B., X. Song, B. Alemayehu, S. S. Wang, J. L. Waddell, J. R. Bouchard, and F. Forma. 2010. “Cost Sharing, Adherence, and Health Outcomes in Patients with Diabetes.” The American Journal of Managed Care 16 (8): 589–600.
31. Goff, D. C., D. M. Lloyd-Jones, and G. Bennett. 2014. “American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.” Journal of the American College of Cardiology 63: 2935–59.
32. Goldman, D. P., G. F. Joyce, and P. Karaca-Mandic. 2006. “Varying Pharmacy Benefits with Clinical Status: The Case of Cholesterol-Lowering Therapy.” The American Journal of Managed Care 12 (1): 21–8.
33. Goldman, D. P., G. F. Joyce, and Y. Zheng. 2007. “Prescription Drug Cost Sharing: Associations with Medication and Medical Utilization and Spending and Health.” Journal of the American Medical Association 298 (1): 61–9.
34. Greenberg, M. R. 2014. “Healthography.” American Journal of Public Health 104 (11): 2022.
35. Hansen, R. A., M. Maciejewski, K. Yu-Isenberg, and J. F. Farley. 2012. “Adherence to Antipsychotics and Cardiometabolic Medication: Association with Health Care Utilization and Costs.” Psychiatric Services 63 (9): 920–8.
36. Harrison, J. A., P. D. Mullen, and L. W. Green. 1992. “A Meta-Analysis of Studies of the Health Belief Model with Adults.” Health Education and Research 7: 107–16.
37. Heisler, M., K. Langa, E. Eby, A. M. Fendrick, M. Kabeto, and J. D. Piette. 2004. “The Health Effects of Restricting Prescription Medication Use Because of Cost.” Medical Care 42: 626–34.
38. Herrin, J., J. St. Andre, K. Kenward, M. S. Joshi, A. M. J. Audet, and S. C. Hines. 2015. “Community Factors and Hospital Readmission Rates.” Health Services Research 50: 23–39.
39. Insull, W. 1997. “The Problem of Compliance to Cholesterol Altering Therapy.” Journal of Internal Medicine 241 (4): 317–25.
40. Joyce, G. F., J. J. Escarce, M. D. Solomon, and D. P. Goldman. 2002. “Employer Drug Benefit Plans and Spending on Prescription Drugs.” Journal of the American Medical Association 288 (14): 1733–9.
41. Karaca-Mandic, P., T. Swenson, J. M. Abraham, and R. L. Kane. 2012. “Association of Medicare Part D Medication Out-of-Pocket Costs with Utilization of Statin Medications.” Health Services Research 48 (4): 1311–33.
42. Leibowitz, A., W. G. Manning, and J. P. Newhouse. 1985. “The Demand for Prescription Drugs as a Function of cost-Sharing.” Social Science & Medicine 21 (10): 1063–9.
43. Leslie, R. S. 2007. “Using Arrays to Calculate Medication Utilization.” Paper# 043–2007, SAS Global Forum [accessed April 15, 2014].
44. Leslie, S. R., F. Gwadry-Sridhar, P. Thiebaud, and B. V. Patel. 2008. “Calculating Medication Compliance, Adherence and Persistence in Administrative Pharmacy Claims Databases.” Pharmaceutical Programming 1 (1): 13–9.
45. Lewey, J., W. H. Shrank, A. D. K. Bowry, E. Kilabuk, T. A. Brennan, and N. K. Choudhry. 2013. “Gender and Racial Disparities in Adherence to Statin Therapy: A Meta-Analysis.” American Heart Journal 165 (5): 665–78.
46. Link, B. G., and J. Phelan. 1995. “Social Conditions as Fundamental Causes of Disease.” Journal of Health and Social Behavior 35: 80–94.
47. Macintyre, S., A. Ellaway, and S. Cummins. 2002. “Place Effects on Health: How Can We Conceptualize, Operationalize and Measure Them?” Social Science & Medicine 55 (1): 125–39.
48. Magzamen, S., S. J. Brandt, and I. B. Tager. 2014. “Examining Household Asthma Management Behavior through a Microeconomic Framework.” Health Education & Behavior 41 (6): 651–62.
49. Mann, D. M., J. P. Allegrante, S. Natarajan, E. A. Halm, and M. Charlson. 2007. “Predictors of Adherence to Statins for Primary Prevention.” Cardiovascular Drugs Therapeutics 21: 311–6.
50. Mann, D. M., M. Woodward, P. Muntner, L. Falzon, and I. Kronish. 2010. “Predictors of Nonadherence to Statins: A Systematic Review and Meta-Analysis.” The Annals of Pharmacotherapy 44 (9): 1410–21.
51. Medina-Inojosa, J., N. Jean, M. Cortes-Bergoderi, and F. Lopez-Jimenez. 2014. “The Hispanic Paradox in Cardiovascular Disease and Total Mortality.” Progress in Cardiovascular Diseases 57 (3): 286–92.
52. Montez, J. K., and E. M. Friedman. 2015. “Educational Attainment and Adult Health: Under What Conditions Is the Association Causal?” Social Science & Medicine 127 (Feb.): 1–7.
53. Munro, S. S., T. Swart. Lewin, and J. Volmink. 2007. “A Review of Health Behavior Theories: How Useful Are These for Developing Interventions to Promote Long-Term Medication Adherence for TB and HIV/AIDS?” BMC Public Health 7: 104.
54. Murphy, G. K., F. A. McAlister, D. L. Weir, L. Tjosvold, and D. T. Eurich. 2014. “Cardiovascular Medication Utilization and Adherence among Adults Living in Rural and Urban Areas: A Systematic Review and Meta-Analysis.” BMC Public Health 14 (1): 544.
55. Nau, D. P. 2014. “Proportion of Days Covered (PDC) as a Preferred Method of Measuring Medication Adherence.” Pharmacy Quality Alliance [accessed on April 15, 2014]. Available at http://pqaalliance.org/resources/adherence.asp
56. NCHS (National Center for Health Statistics). 2016. Health, United States, 2015: With Special Feature on Racial and Ethnic Health Disparities. Hyattsville, MD: Centers for Disease Control and Prevention.
57. Nelson, L. A., M. R. Graham, C. Lindsey, and R. S. Rasu. 2011. “Adherence to Antihyperlipidemic Medication and Lipid Control in Diabetic Veterans Affairs Patients with Psychotic Disorders.” Psychosomatics 52 (4): 310–8.
58. Pencina, M. J., A. M. Navar-Bogga, R. B. D'Agostino, K. Williams, B. Neely, A. D. Sniderman, and E. D. Peterson. 2014. “Application of New Cholesterol Guidelines to a Population Based Sample.” The New England Journal of Medicine 370 (15): 1422–31.
59. Perreault, S., L. Ellia, A. Dragomir, R. Cote, L. Blais, and A. Berard. 2009. “Effect of Statin Adherence on Cerebrovascular Disease in Primary Prevention.” The American Journal of Medicine 122 (7): 647–55.
60. Phelan, J. C., B. G. Link, and P. Tehranifar. 2010. “Social Conditions as Fundamental Causes of Health Inequalities: Theory, Evidence, and Policy Implications.” Journal of Health and Social Behavior 51 (S): S28–40.
61. Poland, B., P. Lehoux, D. Holmes, and G. Andrews. 2005. “How Place Matters: Unpacking Technology and Power in Health and Social Care.” Health & Social Care in the Community 13 (2): 170–80.
62. Rasmussen, J. N., A. Chong, and D. A. Alter. 2007. “Relationship between Adherence to Evidence-Based Pharmacotherapy and Long-Term Mortality after Acute Myocardial Infarction.” Journal of the American Medical Association 297: 177–86.
63. Rezayatmand, R., M. Pavlova, and W. Groot. 2013. “The Impact of Out-of-Pocket Payments on Prevention and Health-Related Life Style: A Systematic Literature Review.” European Journal of Public Health 23 (1): 74–9.
64. Rolnick, S. J., P. A. Pawloski, B. D. Hedblom, S. E. Asche, and R. J. Bruzek. 2013. “Patient Characteristics Associated with Medication Adherence.” Clinical Medicine & Research 11 (2): 54–65.
65. Rosenbaum, L., and W. H. Shrank. 2013. “Taking Our Medicine–Improving Adherence in the Accountability Era.” New England Journal of Medicine 369 (8): 694-5.
66. RTI (Research Triangle Institute). 2012. Accountable Care Organization 2012 Program Analysis: Quality Performance Standards Narrative Measure Specifications. Waltham, MA: RTI International.
67. Sabaté, E. (ed.). 2003. Adherence to Long-Term Therapies: Evidence for Action. Geneva, Switzerland: World Health Organization.
68. Schmittdiel, J. A., A. J. Karter, W. Dyer, M. Parker, C. Uratsu, and J. Chan. 2011. “The Comparative Effectiveness of Mail Order Pharmacy Use vs. Local Pharmacy Use on LDL-C Control in New Statin Users.” Journal of General Internal Medicine 26: 1396–402.
69. Schneeweiss, S., A. R. Patrick, M. Maculre, C. R. Dormuth, and R. J. Glynn. 2007. “Adherence to Statin Therapy under Drug Cost Sharing in Patients with and without Acute Myocardial Infarction: A Population-Based Natural Experiment.” Circulation 115 (16): 2128–35.
70. Smith, W. C., E. Anderson, D. Salinas, R. Horvatek, and D. P. Baker. 2015. “A Meta-Analysis of Education Effects on Chronic Disease: The Causal Dynamics of the Population Education Transition Curve.” Social Science & Medicine 127: 29–40.
71. Sokol, M. C., K. A. McGuigan, R. R. Verbrugge, and R. S. Epstein. 2005. “Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost.” Medical Care 43 (6): 521–30.
72. Solomon, M. D., D. P. Goldman, G. F. Joyce, and J. J. Escarce. 2009. “Cost Sharing and the Initiation of Drug Therapy for the Chronically Ill.” Archives of Internal Medicine 169 (8): 740–8.
73. Stone, N. J., J. Robinson, A. H. Lichtenstein, N. B. Merz, C. B. Blum, R. H. Eckel, A. C. Goldberg, D. Gordon, D. Levy, D. M. Lloyd-Jones, P. McBride, J. S. Schwartz, S. T. Shero, S. C. Smith Jr, K. Watson, and P. W. F. Wilson. 2014. “2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.” Circulation 63: 2889–934.
74. Thiebaud, P., B. V. Patel, and M. B. Nichol. 2008. “The Demand for Statin: The Effect of Copay on Utilization and Compliance.” Health Economics 17: 83–97.
75. Thorpe, C. T., H. Johnson, A. L. Dopp, J. M. Thorpe, K. Ronk, C. M. Everett, M. Palta, D. A. Mott, B. Chewning, L. Schleiden, and M. A. Smith. 2015. “Medication Oversupply in Patients with Diabetes.” Research in Social and Administrative Pharmacy 11 (3): 382–400.
76. Unni, E., and K. B. Farris. 2011. “Determinants of Different Types of Medication Non-Adherence in Cholesterol Lowering and Asthma Maintenance Medications: A Theoretical Approach.” Patient Education and Counseling 83: 382–90.
77. Vaidya, V., M. Hufstader-Gabriel, N. Gangan, S. Shah, and R. Bechtol. 2014. “Utilization of Smoking-Cessation Pharmacotherapy among Chronic Obstructive Pulmonary Disease (COPD) and Lung Cancer Patients.” Current Medical Research & Opinion 30 (6): 1043–50.
78. Wallach-Kildemoes, H., M. Andersen, F. Diderichsen, and T. Lange. 2013. “Adherence to Preventive Statin Therapy According to Socioeconomic Position.” European Journal of Clinical Pharmacology 69 (8): 1553–63.
79. Williams, A., E. Manias, and R. Walker. 2008. “Interventions to Improve Medication Adherence in People with Multiple Chronic Conditions: A Systematic Review.” Journal of Advanced Nursing 63 (2): 132–43.
80. Xu, K. T., S. R. Smith, and T. F. Borders. 2003. “Access to Prescription Drugs among Noninstitutionalized Elderly People in West Texas.” American Journal of Health System Pharmacy 60 (7): 675–82.
81. Ye, X., C. R. Gross, J. Schommer, R. Cline, and W. L. S. Peter. 2007. “Association between Copayment and Adherence to Statin Treatment Initiated after Coronary Heart Disease Hospitalization: A Longitudinal, Retrospective, Cohort Study.” Clinical Therapeutics 29 (12): 2748–57.
82. Yeaw, J. 2009. “Comparing Adherence and Persistence across Six Chronic Medication Classes.” Journal of Managed Care Pharmacy 15 (9): 728–40.
83. Yu, A. P., Y. F. Yu, M. B. Nichol, and F. Gwadry-Sridhar. 2008. “Delay in Filling the Initial Prescription for a Statin: A Potential Early Indicator of Medication Nonpersistence.” Clinical Therapeutics 30: 761–74.